| Survival benefits of primary tumor surgery for synchronous brain metastases: A SEER ‐based population study with propensity‐matched comparative analysis | | |
| Pan-tropomyosin receptor kinase immunohistochemistry is a feasible routine screening strategy for NTRK fusions in mismatch repair-deficient colorectal carcinomas | | 2022 |
| Combinatory anti-tumor activities of AQ4 and temsirolimus against colorectal cancer cells | | |
| Diverting ileostomy is a risk factor for renal impairment during CAPOX therapy | | |
| Role of stereotactic body radiotherapy in multidisciplinary management of liver metastases in patients with colorectal cancer | | |
| Malignancies in HIV | | 2021 |
| Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study | Cancers | 2022 |
| Role of Neoadjuvant therapy in the treatment of patients with colorectal liver metastases | | 2023 |
| Up-to-date evidence on image-guided thermal ablation for metastatic lung tumors: a review | Japanese Journal of Radiology | |
| WEO newsletter | Digestive Endoscopy | 2022 |
| Noninvasive early detection of colorectal cancer by hypermethylation of the LINC00473 promoter in plasma cell-free DNA | Clinical Epigenetics | 2022 |
| Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study | BMC Gastroenterology | 2022 |
| Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy | Cancers | 2022 |
| The role of high-risk features in stage II colon cancer after surgical treatment | Surgery Open Digestive Advance | 2022 |
| Perioperative and oncologic outcomes of interval colectomy performed by acute care surgeons after stenting as a bridge to surgery for left-sided malignant colonic obstruction are non-inferior to the outcomes of colorectal surgeons in the elective setting: single center experience | European Journal of Trauma and Emergency Surgery | |
| Disparities in Surgical Timing and Guideline-Adherent Staging Work-Up for Colon Cancer | Annals of Surgical Oncology | |
| Local Therapies for Colorectal Cancer Oligometastases to the Lung | Current Colorectal Cancer Reports | 2022 |
| Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC) | Cancers | 2022 |
| Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer | PLoS ONE | 2022 |
| Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3 | British Journal of Cancer | |
| Dihydropyrimidine Dehydrogenase Deficiency and Implementation of Upfront DPYD Genotyping | Clinical Pharmacology and Therapeutics | |
| PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies | Cancers | 2022 |
| Comparison of survival outcomes using cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colon versus rectal cancer with peritoneal carcinomatosis in an asian medical center | Journal of Cancer Research and Practice | 2022 |
| CPI Adult Cancer Imaging Special Edition Module | | 2019 |
| Tumor Stroma Ratio and Its Significance in Locally Advanced Colorectal Cancer | Current Oncology | 2022 |
| Genomic Landscape of Primary Tumor Site and Clinical Outcome for Patients with Metastatic Colorectal Cancer Receiving Standard-of-Care Chemotherapy. | Targeted Oncology | 2022 |
| External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort | Cancers | 2022 |
| Comprehensive Genomic Profiling of Circulating Tumor DNA in Patients with Previously Treated Metastatic Colorectal Cancer: Analysis of a Real-World Healthcare Claims Database | Current Oncology | 2022 |
| Extended Lymphadenectomy for Proximal Transverse Colon Cancer: Is There a Place for Standardization? | Medicina (Lithuania) | 2022 |
| THINKING TOO FAST ABOUT CHEMOTHERAPY FOR RESECTABLE COLORECTAL CANCER LIVER METASTASES? | Clinical Colorectal Cancer | 2022 |
| Concordance analysis between liquid biopsy (ctDNA) and tumor DNA molecular profiles from panel-based next-generation sequencing | Revista Espanola De Patologia | 2022 |
| Image_2.pdf | | 2020 |
| Image_1.pdf | | 2020 |
| Data_Sheet_1.pdf | | 2020 |
| Data_Sheet_1.PDF | | 2020 |
| Pelvic CT in addition to MRI to differentiate between rectal and sigmoid cancer on imaging using the sigmoid take-off as a landmark. | Acta Radiologica | 2022 |
| Prognostic significance of the mean corpuscular volume (MCV) and red cell distribution width (RDW) in obstructive colorectal cancer patients with a stent inserted as a bridge to curative surgery. | Surgery Today | 2022 |
| Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial. | British Journal of Cancer | 2021 |
| 9-ING-41, a Small Molecule Inhibitor of GSK-3β, Potentiates the Effects of Chemotherapy on Colorectal Cancer Cells. | Frontiers in Pharmacology | 2021 |
| Advanced Endoscopic Resection Techniques: Endoscopic Submucosal Dissection and Endoscopic Full-Thickness Resection. | Digestive Diseases and Sciences | 2022 |
| Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data. | Pharmacogenomics Journal | 2022 |
| Society for Surgery of the Alimentary Tract Health Care Quality and Outcomes Committee Webinar: Addressing Disparities. | Journal of Gastrointestinal Surgery | 2022 |
| A risk stratification for nodal metastasis in T1 colorectal cancer after successful therapeutic endoscopy. | Gastrointestinal Endoscopy | 2022 |
| Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen. | Journal of Cancer Research and Clinical Oncology | 2022 |
| High Red Cell Distribution Width Is Associated with Worse Prognosis in Early Colorectal Cancer after Curative Resection: A Propensity-Matched Analysis. | Cancers | 2022 |
| Effect of Primary Tumor Location on Second- or Later-Line Treatment With Anti-Epidermal Growth Factor Receptor Antibodies in Patients With Metastatic Colorectal Cancer: A Retrospective Multi-Center Study. | Frontiers in Oncology | 2022 |
| Efficacy and Safety of Systemic Treatments Among Colorectal Cancer Patients: A Network Meta-Analysis of Randomized Controlled Trials. | Frontiers in Oncology | 2021 |
| Classification of early-stage colon cancer with Immunoscore: clinical evidence and case studies. | Future Oncology | 2021 |
| The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients. | Molecular Diagnosis and Therapy | 2022 |
| Circulating Tumor Cell Kinetics and Morphology from the Liquid Biopsy Predict Disease Progression in Patients with Metastatic Colorectal Cancer Following Resection. | Cancers | 2022 |
| The utility of surveillance CT scans in a cohort of survivors of colorectal cancer. | Journal of Cancer Survivorship | 2022 |
| Prognostic Impact of Total Lesion Glycolysis (TLG) from Preoperative F-FDG PET/CT in Stage II/III Colorectal Adenocarcinoma: Extending the Value of PET/CT for Resectable Disease. | Cancers | 2022 |
| Malignant colon polyps: predicting lymph node metastasis following endoscopic excision. | International Journal of Colorectal Disease | 2022 |
| Early Postoperative Serum Carcinoembryonic Antigen Is a Stronger Independent Prognostic Factor for Stage II Colorectal Cancer Patients Than T4 Stage and Preoperative CEA. | Frontiers in Oncology | 2021 |
| Perineural Invasion is a Powerful Prognostic Factor for Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy. | Annals of Surgical Oncology | 2022 |
| Solitary pleural metastasis in rectal cancer. | Clinical Journal of Gastroenterology | 2022 |
| Liver-Directed Treatment Options Following Liver Tumor Recurrence: A Review of the Literature. | Frontiers in Oncology | 2022 |
| Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe. | Journal of Personalized Medicine | 2022 |
| A scalable high-throughput targeted next-generation sequencing assay for comprehensive genomic profiling of solid tumors | PLoS ONE | 2021 |
| Colon Cancer: Survivorship Care Case Study, Care Plan, and Commentaries | Clinical Journal of Oncology Nursing | 2021 |
| Indications for conversion hepatectomy for initially unresectable colorectal cancer with liver metastasis | Surgery Today | 2021 |
| A Novel Prognostic Biomarker Panel for Early-Stage Colon Carcinoma | Cancers | 2021 |
| Predictive factors of survival of colorectal cancer patients after para-aortic lymph node metastasis | International Journal of Clinical Oncology | 2021 |
| Colorectal Cancer: Postoperative Adjuvant Therapy and Surveillance | | 2022 |
| Sporadic and Inherited Colorectal Cancer: How Epidemiology and Molecular Biology Guide Screening and Treatment | | 2022 |
| Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist | Cancers | 2021 |
| Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment | Frontiers in Oncology | 2021 |
| Post-Marketing Surveillance of a generic Oxaliplatin (Alvoxal) in Iranian Patients with Cancer. | Current Therapeutic Research | 2022 |
| Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method | Klinichna Khirurhiia | 2020 |
| Failure to Refer Patients with Colorectal Liver Metastases to a Multidisciplinary Oncology Team Should be a "Never-Event" | Journal of the National Medical Association | 2020 |
| Aberrant Partial Chromosomal Instability With Chemotherapeutically Resistant Metachronous Colorectal Cancer Following a Synchronous Primary Colorectal Cancer: A Case Report | Cureus | 2020 |
| Medical Oncology | | 2008 |
| Endoscopic Colon Surveillance | | 2006 |
| Surveillance after Primary Therapy | | 2007 |
| Colonic Conditions: Adenomatous Polyps | | 2020 |
| Colorectal Cancer in Elderly Patients: Considerations in Treatment and Management | | 2020 |
| Benign and Malignant Tumors of the Liver | | 2020 |
| Colorectal Cancer in Older Adults: Surgical Issues | | 2020 |
| Colorectal Cancer: Liver Metastatic Disease | | 2020 |
| Emergency surgery for CRC | | 2022 |
| Molecular Biomarkers: A Review of Multiple Applications in Clinical Care of Colorectal Cancer | Clinical Journal of Oncology Nursing | 2020 |
| A phase 1b expansion study of TAS-102 with oxaliplatin for refractory metastatic colorectal cancer | Cancer | 2021 |
| Capecitabine Plus Bevacizumab as First-Line Therapy for Patients with Metastatic Colorectal Cancer and Poor Performance Status | Journal of Nippon Medical School | 2021 |
| [Tumor budding in colorectal cancer-Information for clinical use and instructions for practical evaluation] | Der Pathologe | 2021 |
| Sampling error in the diagnosis of colorectal cancer is associated with delay to surgery: a retrospective cohort study | Surgical Endoscopy and Other Interventional Techniques | 2021 |
| Prognostic Significance of Preoperative Globulin-to-albumin Ratio in Obstructive Colorectal Cancer Patients Who Underwent Curative Surgery after Stenting | Journal of the Anus, Rectum and Colon | 2021 |
| Immune response activation following hyperthermic intraperitoneal chemotherapy for peritoneal metastases: A pilot study | World Journal of Clinical Oncology | 2020 |
| El paciente superviviente al cáncer en la consulta de atención primaria | FMC Formacion Medica Continuada En Atencion Primaria | 2020 |
| Lymph Node Morphology in Stage II Colorectal Cancer | | |
| Prognosis and Management of Recurrent Metastatic Colorectal Cancer | | 2020 |
| Molecular Testing in Ovarian Cancer: Recommendations and Treatment Considerations | | 2020 |
| Systemic Therapy for Colorectal Cancer Liver Metastases: Sorting Through the Options | | 2020 |
| Revisiting oral fluoropyrimidine with cetuximab in metastatic colorectal cancer: Real-world data in Chinese population | World Journal of Gastrointestinal Oncology | 2019 |
| GI Including GIST | | 2020 |
| Association of Kras mutation with tumor deposit status and overall survival of colorectal cancer | | |
| Endoscopic submucosal dissection in the West | International Journal of Gastrointestinal Intervention | 2019 |
| Metastatic Colorectal Cancer | | 2019 |
| Adjuvant Therapy for Colorectal Cancer | | 2019 |
| Peritoneal Carcinomatosis and Other Emergencies Not Related to Primary Colorectal Cancer | Hot Topics in Acute Care Surgery and Trauma | 2019 |
| Molecular Diagnostics and Genomic Profiling in Individualized Therapies of Gastrointestinal Cancers | | 2019 |
| Colorectal Cancer Screening and Women | | 2019 |
| Colon Cancer | | 2019 |
| Colorectal Cancer in Elderly Patients: Considerations in Treatment and Management | | 2019 |
| Hepatobiliary Malignancies | | 2018 |
| Second-Line Chemotherapy in Colorectal Cancer | Nihon Daicho Komonbyo Gakkai Zasshi | 2018 |
| Kolorektales Karzinom | | 2018 |
| Medical Oncology Management of Hereditary Colorectal Cancer | | 2018 |
| Benign and Malignant Tumors of the Liver | | 2017 |
| Right Hemicolectomy | | 2016 |
| Translation: Companion Biomarkers: Paving the Pathway to Personalized Treatment for Cancer | Laboratory Medicine Online | 2015 |
| Pyrimidine Antimetabolites☆ | | 2014 |
| Preoperative staging with positron emission tomography in patients with colorectal cancer | Annals of Coloproctology | 2014 |
| Serological Markers of Digestive Tract Cancers | Molecular Pathology Library | 2013 |
| Colorectal Cancer | | 2012 |
| References | | 2012 |
| Application of molecular medicine to pancreatic cancer | Suizo | 2010 |
| Colorectal Cancer | | 2010 |
| Percutaneous Navigation under Local Anesthesia for Computed Tomography-Guided Microwave Ablation of Malignant Liver Lesions Located in the Hepatic Dome | Medicina (Lithuania) | 2021 |
| Glycemic Variability Within 1 Year Following Surgery for Stage II-III Colon Cancer | Biological Research for Nursing | 2022 |
| A national evaluation of the use and survival impact of adjuvant chemotherapy in Stage II colon cancer from the national cancer database | Colorectal Disease | 2021 |
| Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer | World Journal of Gastrointestinal Oncology | 2020 |
| Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients | World Journal of Gastroenterology | 2015 |
| The anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancer | Oncotarget | 2015 |
| The Use of Nivolumab in Colorectal Cancer with Lynch Syndrome. A Case Report | Malignant Tumours | 2020 |
| [Panitumumab-treatment of metastatic colorectal cancer] | | 2009 |
| Limited detection of small (≤ 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection | PLoS ONE | 2017 |
| Malignant Potential of Gastrointestinal Cancers Assessed by Structural Equation Modeling | PLoS ONE | 2016 |
| Transverse colon cancer presenting as acute abdominal wall abscess | BMJ Case Reports | 2014 |
| TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted Sequencing | | |
| Image-Guided Thermal Ablation for Colorectal Liver Metastases | Techniques in Vascular and Interventional Radiology | 2020 |
| Clinical Treatment in Colorectal Cancer: Other Aspects | | 2017 |
| Colorectal Cancer in Older Adults: Surgical Issues | | 2019 |
| Colon and Rectum | | 2017 |
| Lymph Node Harvesting in Colorectal Cancer: The Role of Fluorescence Lymphangiography | | 2020 |
| Genomic Cancer Risk Assessment | | 2020 |
| Laparoscopic Right Colectomy for Malignant Disease | | 2020 |
| The Clinical Utility of Bevacizumab | | 2008 |
| as an Emerging Predictive Biomarker in Ovarian Cancer | Diagnostics | 2021 |
| [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology] | Revista Espanola De Patologia | 2021 |
| Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases | Annals of Surgical Oncology | 2021 |
| Provisional Clinical Opinions (PCOs) Recommended by the Surgical Treatment Working Group for Vulnerable Elderly Patients inColorectal Cancer: General Remarks on Surgical Treatment | Nihon Daicho Komonbyo Gakkai Zasshi | 2021 |
| Diarylureas as Antitumor Agents | Applied Sciences (Switzerland) | 2021 |
| Treatment and Survival Disparities of Colon Cancer in the Texas-Mexico Border Population: Cancer Disparities in Border Population | Journal of Surgical Research | 2021 |
| Barriers to Referral for CS/HIPEC Identified Using a Tailoring Grid Methodology: Interviews With Stakeholders in New York State | Journal of Surgical Research | 2021 |
| HIPEC Trials and the US: A Review and Call to Action | Annals of Surgical Oncology | 2021 |
| MSI testing : What's new? What should be considered? | Der Pathologe | 2021 |
| Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy | European Journal of Radiology | 2021 |
| BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases | Cancer Medicine | 2021 |
| Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study | Cancers | 2021 |
| Real-World Evaluation of Universal Germline Screening for Cancer Treatment-Relevant Pharmacogenes | Cancers | 2021 |
